nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—Prednisone—ankylosing spondylitis	0.102	0.187	CbGbCtD
Sitaxentan—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0812	0.149	CbGbCtD
Sitaxentan—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0635	0.116	CbGbCtD
Sitaxentan—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0615	0.113	CbGbCtD
Sitaxentan—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0528	0.0968	CbGbCtD
Sitaxentan—CYP3A4—Betamethasone—ankylosing spondylitis	0.0528	0.0968	CbGbCtD
Sitaxentan—CYP3A4—Prednisolone—ankylosing spondylitis	0.0521	0.0955	CbGbCtD
Sitaxentan—CYP3A4—Prednisone—ankylosing spondylitis	0.0492	0.0902	CbGbCtD
Sitaxentan—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0307	0.0563	CbGbCtD
Sitaxentan—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000515	0.00113	CcSEcCtD
Sitaxentan—Bradycardia—Betamethasone—ankylosing spondylitis	0.000514	0.00113	CcSEcCtD
Sitaxentan—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000514	0.00113	CcSEcCtD
Sitaxentan—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000507	0.00112	CcSEcCtD
Sitaxentan—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000507	0.00112	CcSEcCtD
Sitaxentan—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000505	0.00111	CcSEcCtD
Sitaxentan—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000505	0.00111	CcSEcCtD
Sitaxentan—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000504	0.00111	CcSEcCtD
Sitaxentan—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000501	0.0011	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0005	0.0011	CcSEcCtD
Sitaxentan—Ataxia—Methotrexate—ankylosing spondylitis	0.000499	0.0011	CcSEcCtD
Sitaxentan—Weight decreased—Prednisone—ankylosing spondylitis	0.000497	0.00109	CcSEcCtD
Sitaxentan—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000495	0.00109	CcSEcCtD
Sitaxentan—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00049	0.00108	CcSEcCtD
Sitaxentan—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000489	0.00108	CcSEcCtD
Sitaxentan—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000486	0.00107	CcSEcCtD
Sitaxentan—Visual impairment—Betamethasone—ankylosing spondylitis	0.000486	0.00107	CcSEcCtD
Sitaxentan—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000486	0.00107	CcSEcCtD
Sitaxentan—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000483	0.00106	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000483	0.00106	CcSEcCtD
Sitaxentan—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00048	0.00106	CcSEcCtD
Sitaxentan—Breast disorder—Methotrexate—ankylosing spondylitis	0.00048	0.00106	CcSEcCtD
Sitaxentan—Malaise—Prednisolone—ankylosing spondylitis	0.000475	0.00105	CcSEcCtD
Sitaxentan—Vertigo—Prednisolone—ankylosing spondylitis	0.000473	0.00104	CcSEcCtD
Sitaxentan—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000472	0.00104	CcSEcCtD
Sitaxentan—Eye disorder—Betamethasone—ankylosing spondylitis	0.000472	0.00104	CcSEcCtD
Sitaxentan—Asthma—Methotrexate—ankylosing spondylitis	0.000459	0.00101	CcSEcCtD
Sitaxentan—Angiopathy—Betamethasone—ankylosing spondylitis	0.000458	0.00101	CcSEcCtD
Sitaxentan—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000458	0.00101	CcSEcCtD
Sitaxentan—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000454	0.001	CcSEcCtD
Sitaxentan—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000449	0.000989	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000448	0.000987	CcSEcCtD
Sitaxentan—Bradycardia—Prednisone—ankylosing spondylitis	0.000447	0.000985	CcSEcCtD
Sitaxentan—Alopecia—Betamethasone—ankylosing spondylitis	0.000446	0.000982	CcSEcCtD
Sitaxentan—Alopecia—Dexamethasone—ankylosing spondylitis	0.000446	0.000982	CcSEcCtD
Sitaxentan—Discomfort—Prednisolone—ankylosing spondylitis	0.000443	0.000975	CcSEcCtD
Sitaxentan—Haemoglobin—Prednisone—ankylosing spondylitis	0.000442	0.000973	CcSEcCtD
Sitaxentan—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00044	0.000969	CcSEcCtD
Sitaxentan—Haemorrhage—Prednisone—ankylosing spondylitis	0.00044	0.000968	CcSEcCtD
Sitaxentan—Malaise—Triamcinolone—ankylosing spondylitis	0.000437	0.000961	CcSEcCtD
Sitaxentan—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000436	0.000959	CcSEcCtD
Sitaxentan—Malaise—Methylprednisolone—ankylosing spondylitis	0.000436	0.000959	CcSEcCtD
Sitaxentan—Vertigo—Triamcinolone—ankylosing spondylitis	0.000435	0.000958	CcSEcCtD
Sitaxentan—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000434	0.000956	CcSEcCtD
Sitaxentan—Oedema—Prednisolone—ankylosing spondylitis	0.00043	0.000946	CcSEcCtD
Sitaxentan—Dysuria—Methotrexate—ankylosing spondylitis	0.000429	0.000945	CcSEcCtD
Sitaxentan—Tachycardia—Prednisolone—ankylosing spondylitis	0.000419	0.000923	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000419	0.000922	CcSEcCtD
Sitaxentan—Eye disorder—Prednisone—ankylosing spondylitis	0.000411	0.000904	CcSEcCtD
Sitaxentan—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000409	0.000901	CcSEcCtD
Sitaxentan—Infestation—Methotrexate—ankylosing spondylitis	0.000409	0.000901	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000409	0.000899	CcSEcCtD
Sitaxentan—Flushing—Prednisone—ankylosing spondylitis	0.000408	0.000898	CcSEcCtD
Sitaxentan—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000408	0.000897	CcSEcCtD
Sitaxentan—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000408	0.000897	CcSEcCtD
Sitaxentan—Discomfort—Triamcinolone—ankylosing spondylitis	0.000407	0.000897	CcSEcCtD
Sitaxentan—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000406	0.000895	CcSEcCtD
Sitaxentan—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000403	0.000888	CcSEcCtD
Sitaxentan—Renal failure—Methotrexate—ankylosing spondylitis	0.000402	0.000885	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—ankylosing spondylitis	0.000399	0.000878	CcSEcCtD
Sitaxentan—Angiopathy—Prednisone—ankylosing spondylitis	0.000399	0.000878	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000398	0.000876	CcSEcCtD
Sitaxentan—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000398	0.000875	CcSEcCtD
Sitaxentan—Immune system disorder—Prednisone—ankylosing spondylitis	0.000397	0.000874	CcSEcCtD
Sitaxentan—Malaise—Dexamethasone—ankylosing spondylitis	0.000396	0.000872	CcSEcCtD
Sitaxentan—Malaise—Betamethasone—ankylosing spondylitis	0.000396	0.000872	CcSEcCtD
Sitaxentan—Oedema—Triamcinolone—ankylosing spondylitis	0.000395	0.00087	CcSEcCtD
Sitaxentan—Vertigo—Betamethasone—ankylosing spondylitis	0.000395	0.000869	CcSEcCtD
Sitaxentan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000395	0.000869	CcSEcCtD
Sitaxentan—Infection—Triamcinolone—ankylosing spondylitis	0.000393	0.000864	CcSEcCtD
Sitaxentan—Infection—Methylprednisolone—ankylosing spondylitis	0.000392	0.000862	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—ankylosing spondylitis	0.00039	0.000859	CcSEcCtD
Sitaxentan—Insomnia—Prednisolone—ankylosing spondylitis	0.000389	0.000856	CcSEcCtD
Sitaxentan—Alopecia—Prednisone—ankylosing spondylitis	0.000388	0.000855	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000387	0.000852	CcSEcCtD
Sitaxentan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000387	0.000851	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—ankylosing spondylitis	0.000386	0.00085	CcSEcCtD
Sitaxentan—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000386	0.000849	CcSEcCtD
Sitaxentan—Mental disorder—Prednisone—ankylosing spondylitis	0.000385	0.000848	CcSEcCtD
Sitaxentan—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000385	0.000847	CcSEcCtD
Sitaxentan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000383	0.000843	CcSEcCtD
Sitaxentan—Malnutrition—Prednisone—ankylosing spondylitis	0.000383	0.000842	CcSEcCtD
Sitaxentan—Discomfort—Dexamethasone—ankylosing spondylitis	0.00037	0.000814	CcSEcCtD
Sitaxentan—Discomfort—Betamethasone—ankylosing spondylitis	0.00037	0.000814	CcSEcCtD
Sitaxentan—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000369	0.000813	CcSEcCtD
Sitaxentan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000368	0.000811	CcSEcCtD
Sitaxentan—Pain—Prednisolone—ankylosing spondylitis	0.000368	0.000809	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000367	0.000809	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—ankylosing spondylitis	0.000367	0.000809	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000363	0.000799	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00036	0.000793	CcSEcCtD
Sitaxentan—Oedema—Dexamethasone—ankylosing spondylitis	0.000359	0.000789	CcSEcCtD
Sitaxentan—Oedema—Betamethasone—ankylosing spondylitis	0.000359	0.000789	CcSEcCtD
Sitaxentan—Insomnia—Triamcinolone—ankylosing spondylitis	0.000357	0.000787	CcSEcCtD
Sitaxentan—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000357	0.000785	CcSEcCtD
Sitaxentan—Infection—Dexamethasone—ankylosing spondylitis	0.000356	0.000784	CcSEcCtD
Sitaxentan—Infection—Betamethasone—ankylosing spondylitis	0.000356	0.000784	CcSEcCtD
Sitaxentan—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000355	0.000782	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000354	0.00078	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—ankylosing spondylitis	0.000354	0.000779	CcSEcCtD
Sitaxentan—Anaemia—Prednisone—ankylosing spondylitis	0.000354	0.000779	CcSEcCtD
Sitaxentan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000352	0.000774	CcSEcCtD
Sitaxentan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000352	0.000774	CcSEcCtD
Sitaxentan—Agitation—Prednisone—ankylosing spondylitis	0.000352	0.000774	CcSEcCtD
Sitaxentan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000351	0.000773	CcSEcCtD
Sitaxentan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000351	0.000773	CcSEcCtD
Sitaxentan—Tachycardia—Betamethasone—ankylosing spondylitis	0.00035	0.00077	CcSEcCtD
Sitaxentan—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00035	0.00077	CcSEcCtD
Sitaxentan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000348	0.000766	CcSEcCtD
Sitaxentan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000347	0.000764	CcSEcCtD
Sitaxentan—Malaise—Prednisone—ankylosing spondylitis	0.000345	0.00076	CcSEcCtD
Sitaxentan—Vertigo—Prednisone—ankylosing spondylitis	0.000344	0.000757	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—ankylosing spondylitis	0.000343	0.000756	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—ankylosing spondylitis	0.000343	0.000754	CcSEcCtD
Sitaxentan—Anorexia—Betamethasone—ankylosing spondylitis	0.000342	0.000752	CcSEcCtD
Sitaxentan—Anorexia—Dexamethasone—ankylosing spondylitis	0.000342	0.000752	CcSEcCtD
Sitaxentan—Urticaria—Prednisolone—ankylosing spondylitis	0.000341	0.000752	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000341	0.00075	CcSEcCtD
Sitaxentan—Fatigue—Triamcinolone—ankylosing spondylitis	0.000341	0.00075	CcSEcCtD
Sitaxentan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00034	0.000748	CcSEcCtD
Sitaxentan—Pain—Triamcinolone—ankylosing spondylitis	0.000338	0.000744	CcSEcCtD
Sitaxentan—Hypotension—Betamethasone—ankylosing spondylitis	0.000335	0.000738	CcSEcCtD
Sitaxentan—Hypotension—Dexamethasone—ankylosing spondylitis	0.000335	0.000738	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—ankylosing spondylitis	0.000333	0.000734	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000332	0.00073	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000331	0.000729	CcSEcCtD
Sitaxentan—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000326	0.000717	CcSEcCtD
Sitaxentan—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000325	0.000715	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—ankylosing spondylitis	0.000325	0.000715	CcSEcCtD
Sitaxentan—Insomnia—Betamethasone—ankylosing spondylitis	0.000324	0.000714	CcSEcCtD
Sitaxentan—Insomnia—Dexamethasone—ankylosing spondylitis	0.000324	0.000714	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000324	0.000712	CcSEcCtD
Sitaxentan—Discomfort—Prednisone—ankylosing spondylitis	0.000322	0.000709	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—ankylosing spondylitis	0.000322	0.000708	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—ankylosing spondylitis	0.00032	0.000704	CcSEcCtD
Sitaxentan—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000317	0.000697	CcSEcCtD
Sitaxentan—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000316	0.000695	CcSEcCtD
Sitaxentan—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000316	0.000695	CcSEcCtD
Sitaxentan—Urticaria—Triamcinolone—ankylosing spondylitis	0.000314	0.000691	CcSEcCtD
Sitaxentan—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000313	0.00069	CcSEcCtD
Sitaxentan—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000312	0.000688	CcSEcCtD
Sitaxentan—Oedema—Prednisone—ankylosing spondylitis	0.000312	0.000687	CcSEcCtD
Sitaxentan—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000312	0.000686	CcSEcCtD
Sitaxentan—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000312	0.000686	CcSEcCtD
Sitaxentan—Infection—Prednisone—ankylosing spondylitis	0.00031	0.000683	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00031	0.000681	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00031	0.000681	CcSEcCtD
Sitaxentan—Fatigue—Betamethasone—ankylosing spondylitis	0.000309	0.000681	CcSEcCtD
Sitaxentan—Fatigue—Dexamethasone—ankylosing spondylitis	0.000309	0.000681	CcSEcCtD
Sitaxentan—Pain—Betamethasone—ankylosing spondylitis	0.000307	0.000675	CcSEcCtD
Sitaxentan—Pain—Dexamethasone—ankylosing spondylitis	0.000307	0.000675	CcSEcCtD
Sitaxentan—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000306	0.000674	CcSEcCtD
Sitaxentan—Tachycardia—Prednisone—ankylosing spondylitis	0.000305	0.000671	CcSEcCtD
Sitaxentan—Skin disorder—Prednisone—ankylosing spondylitis	0.000303	0.000668	CcSEcCtD
Sitaxentan—Anorexia—Prednisone—ankylosing spondylitis	0.000298	0.000655	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000297	0.000653	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—ankylosing spondylitis	0.000296	0.000651	CcSEcCtD
Sitaxentan—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000296	0.00065	CcSEcCtD
Sitaxentan—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000296	0.00065	CcSEcCtD
Sitaxentan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000291	0.000641	CcSEcCtD
Sitaxentan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000291	0.00064	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—ankylosing spondylitis	0.000288	0.000635	CcSEcCtD
Sitaxentan—Vertigo—Methotrexate—ankylosing spondylitis	0.000287	0.000632	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—ankylosing spondylitis	0.000286	0.00063	CcSEcCtD
Sitaxentan—Urticaria—Betamethasone—ankylosing spondylitis	0.000285	0.000627	CcSEcCtD
Sitaxentan—Urticaria—Dexamethasone—ankylosing spondylitis	0.000285	0.000627	CcSEcCtD
Sitaxentan—Dizziness—Prednisolone—ankylosing spondylitis	0.000284	0.000626	CcSEcCtD
Sitaxentan—Asthenia—Triamcinolone—ankylosing spondylitis	0.000284	0.000624	CcSEcCtD
Sitaxentan—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000283	0.000624	CcSEcCtD
Sitaxentan—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000283	0.000624	CcSEcCtD
Sitaxentan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000283	0.000623	CcSEcCtD
Sitaxentan—Insomnia—Prednisone—ankylosing spondylitis	0.000282	0.000622	CcSEcCtD
Sitaxentan—Dyspepsia—Prednisone—ankylosing spondylitis	0.000275	0.000605	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—ankylosing spondylitis	0.000272	0.000599	CcSEcCtD
Sitaxentan—Decreased appetite—Prednisone—ankylosing spondylitis	0.000271	0.000598	CcSEcCtD
Sitaxentan—Rash—Prednisolone—ankylosing spondylitis	0.000271	0.000596	CcSEcCtD
Sitaxentan—Dermatitis—Prednisolone—ankylosing spondylitis	0.000271	0.000596	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00027	0.000595	CcSEcCtD
Sitaxentan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00027	0.000594	CcSEcCtD
Sitaxentan—Fatigue—Prednisone—ankylosing spondylitis	0.000269	0.000593	CcSEcCtD
Sitaxentan—Headache—Prednisolone—ankylosing spondylitis	0.000269	0.000593	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—ankylosing spondylitis	0.000269	0.000592	CcSEcCtD
Sitaxentan—Constipation—Prednisone—ankylosing spondylitis	0.000267	0.000588	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—ankylosing spondylitis	0.000263	0.000579	CcSEcCtD
Sitaxentan—Dizziness—Triamcinolone—ankylosing spondylitis	0.000261	0.000575	CcSEcCtD
Sitaxentan—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000261	0.000574	CcSEcCtD
Sitaxentan—Infection—Methotrexate—ankylosing spondylitis	0.000259	0.000571	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000257	0.000566	CcSEcCtD
Sitaxentan—Asthenia—Dexamethasone—ankylosing spondylitis	0.000257	0.000566	CcSEcCtD
Sitaxentan—Asthenia—Betamethasone—ankylosing spondylitis	0.000257	0.000566	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000256	0.000563	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000256	0.000563	CcSEcCtD
Sitaxentan—Nausea—Prednisolone—ankylosing spondylitis	0.000255	0.000562	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—ankylosing spondylitis	0.000254	0.000558	CcSEcCtD
Sitaxentan—Vomiting—Triamcinolone—ankylosing spondylitis	0.000251	0.000553	CcSEcCtD
Sitaxentan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000251	0.000552	CcSEcCtD
Sitaxentan—Rash—Triamcinolone—ankylosing spondylitis	0.000249	0.000549	CcSEcCtD
Sitaxentan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000249	0.000548	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—ankylosing spondylitis	0.000249	0.000548	CcSEcCtD
Sitaxentan—Rash—Methylprednisolone—ankylosing spondylitis	0.000249	0.000547	CcSEcCtD
Sitaxentan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000248	0.000547	CcSEcCtD
Sitaxentan—Urticaria—Prednisone—ankylosing spondylitis	0.000248	0.000546	CcSEcCtD
Sitaxentan—Headache—Triamcinolone—ankylosing spondylitis	0.000248	0.000545	CcSEcCtD
Sitaxentan—Headache—Methylprednisolone—ankylosing spondylitis	0.000247	0.000544	CcSEcCtD
Sitaxentan—Body temperature increased—Prednisone—ankylosing spondylitis	0.000247	0.000543	CcSEcCtD
Sitaxentan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000245	0.00054	CcSEcCtD
Sitaxentan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000245	0.00054	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—ankylosing spondylitis	0.000244	0.000537	CcSEcCtD
Sitaxentan—Dizziness—Dexamethasone—ankylosing spondylitis	0.000237	0.000522	CcSEcCtD
Sitaxentan—Dizziness—Betamethasone—ankylosing spondylitis	0.000237	0.000522	CcSEcCtD
Sitaxentan—Insomnia—Methotrexate—ankylosing spondylitis	0.000236	0.00052	CcSEcCtD
Sitaxentan—Nausea—Triamcinolone—ankylosing spondylitis	0.000235	0.000517	CcSEcCtD
Sitaxentan—Nausea—Methylprednisolone—ankylosing spondylitis	0.000234	0.000516	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—ankylosing spondylitis	0.000232	0.000511	CcSEcCtD
Sitaxentan—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00023	0.000506	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00023	0.000506	CcSEcCtD
Sitaxentan—Vomiting—Betamethasone—ankylosing spondylitis	0.000228	0.000502	CcSEcCtD
Sitaxentan—Vomiting—Dexamethasone—ankylosing spondylitis	0.000228	0.000502	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000227	0.000499	CcSEcCtD
Sitaxentan—Rash—Dexamethasone—ankylosing spondylitis	0.000226	0.000498	CcSEcCtD
Sitaxentan—Rash—Betamethasone—ankylosing spondylitis	0.000226	0.000498	CcSEcCtD
Sitaxentan—Dermatitis—Betamethasone—ankylosing spondylitis	0.000226	0.000497	CcSEcCtD
Sitaxentan—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000226	0.000497	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000225	0.000496	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—ankylosing spondylitis	0.000225	0.000495	CcSEcCtD
Sitaxentan—Headache—Dexamethasone—ankylosing spondylitis	0.000225	0.000495	CcSEcCtD
Sitaxentan—Headache—Betamethasone—ankylosing spondylitis	0.000225	0.000495	CcSEcCtD
Sitaxentan—Asthenia—Prednisone—ankylosing spondylitis	0.000224	0.000493	CcSEcCtD
Sitaxentan—Pain—Methotrexate—ankylosing spondylitis	0.000223	0.000491	CcSEcCtD
Sitaxentan—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000215	0.000473	CcSEcCtD
Sitaxentan—Diarrhoea—Prednisone—ankylosing spondylitis	0.000214	0.00047	CcSEcCtD
Sitaxentan—Nausea—Dexamethasone—ankylosing spondylitis	0.000213	0.000469	CcSEcCtD
Sitaxentan—Nausea—Betamethasone—ankylosing spondylitis	0.000213	0.000469	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—ankylosing spondylitis	0.000207	0.000456	CcSEcCtD
Sitaxentan—Dizziness—Prednisone—ankylosing spondylitis	0.000207	0.000455	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000206	0.000454	CcSEcCtD
Sitaxentan—Vomiting—Prednisone—ankylosing spondylitis	0.000199	0.000437	CcSEcCtD
Sitaxentan—Rash—Prednisone—ankylosing spondylitis	0.000197	0.000433	CcSEcCtD
Sitaxentan—Dermatitis—Prednisone—ankylosing spondylitis	0.000197	0.000433	CcSEcCtD
Sitaxentan—Headache—Prednisone—ankylosing spondylitis	0.000196	0.000431	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000192	0.000423	CcSEcCtD
Sitaxentan—Asthenia—Methotrexate—ankylosing spondylitis	0.000187	0.000412	CcSEcCtD
Sitaxentan—Nausea—Prednisone—ankylosing spondylitis	0.000185	0.000408	CcSEcCtD
Sitaxentan—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000179	0.000393	CcSEcCtD
Sitaxentan—Dizziness—Methotrexate—ankylosing spondylitis	0.000173	0.00038	CcSEcCtD
Sitaxentan—Vomiting—Methotrexate—ankylosing spondylitis	0.000166	0.000365	CcSEcCtD
Sitaxentan—Rash—Methotrexate—ankylosing spondylitis	0.000165	0.000362	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—ankylosing spondylitis	0.000164	0.000362	CcSEcCtD
Sitaxentan—Headache—Methotrexate—ankylosing spondylitis	0.000164	0.00036	CcSEcCtD
Sitaxentan—Nausea—Methotrexate—ankylosing spondylitis	0.000155	0.000341	CcSEcCtD
